share_log

华东医药:监事会关于调整2022年限制性股票激励计划回购价格及回购注销部分限制性股票的核查意见(更新前)

Huadong Medicine: The Supervisory Board's verification opinion on the adjustment of the repurchase price and cancellation of restricted stocks of the 2022 restricted stock incentive plan (pre-update).

Sensex a share ·  May 30
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more